Oncologists Accepting Medicare in MassachusettsPage 7

Charlene Mantia, M.D.

Instructor in Medicine, Harvard Medical School

Oncology

Payal Gupta, MD

Oncology

Genevieve Boland, MD, PHD

Vice Chair of Research, Department of Surgery; Director, Therapeutic Intralesional Program; Surgical Director, Termeer Center for Targeted Therapies; Associate Professor, Harvard Medical School

Oncology

Othon Iliopoulos, MD

Oncology

Martha Wadleigh, MD

Director, Inpatient Oncology; Assistant Professor of Medicine, Harvard Medical School

Oncology

Raul Uppot, MD

Chief of Interventional Radiology, Academic Medical Centers, Mass General Brigham; Associate Professor of Radiology, Harvard Medical School; Director, Abdominal Imaging Fellowship, Massachusetts General Hospital; Executive Director, Mass General Brigham Medical Extended Reality Lab

Oncology

Otto Metzger, M.D.

Director, International Strategic Initiatives; Assistant Professor of Medicine, Harvard Medical School

Oncology

Rochelle Scheib, MD

Professor of Medicine, Harvard Medical School

Oncology

Rizwan Haq, MD, PHD

Assistant Professor, Harvard Medical School

Oncology

Shayna Sarosiek, MD

Senior Physician; Assistant Professor of Medicine, Harvard Medical School

Oncology

Ting Bao, M.D.

Director of the Zakim Center for Integrative Therapies and Healthy Living at the Dana-Farber Cancer Institute. She was a joint faculty member at Memoria

Oncology

Amy Bregar, MD

Assistant Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Oncology

David Jackman, M.D.

Director for Clinical Pathways and New Business Initiatives. His research interests include targeted therapies in lung cancer and mesothelioma, and canc; Senior Physician

Oncology

Laura Spring, M.D.

Assistant Professor of Medicine, Harvard Medical School

Oncology

Arielle Langer, MD, MPH

Instructor in Medicine, Harvard Medical School; Assistant Professor of Medicine, Brigham and Women's Hospital

Oncology

Christopher Lathan, M.D. M.S. M.P.H.

Chair at Dana Farber, and he serves as Dana-Farber’s Chief Clinical Access Officer. He is the Founding Director of Dana-Farber’s Cancer Care Access Program; Chief Medical Officer and Medical Director of Dana-Farber Cancer Institute’s Regional Campuses and currently serves as the chair for American Society of Cl

Oncology

Colin Weekes, M.D.

Director, Medical Oncology Research for Pancreatic Cancer, Tucker Gosnell Center for Gastrointestinal Cancers; Christopher D. Horner Endowed Chair in Pancreatic Cancer; Associate Professor of Medicine, Harvard Medical School

Oncology

Michael Serzan, MD

Instructor of Medicine at Harvard Medical School.; Chief Resident at Medstar Georgetown University Hospital. Dr. Serzan joined the Lank Center for Genitourinary Oncology in 2022 and has expertise in t

Oncology

Kenneth Kehl, MD

Director of Clinical Research; Assistant Professor of Medicine, Harvard Medical School

Oncology

David Ting, MD

Associate Professor of Medicine, Harvard Medical School; Associate Clinical Director for Innovation, Mass General Brigham Cancer Institute; Physician, Medicine-Hematology and Medical Oncology, Massachusetts General Hospital

Oncology